Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
Abstract Background Glioblastoma is devastating cancer with a high frequency of occurrence and poor survival rate and it is urgent to discover novel glioblastoma-specific antigens for the therapy. Cancer-germline genes are known to be related to the formation and progression of several cancer types...
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMC
2020-07-01
|
| Serie: | BMC Cancer |
| Ämnen: | |
| Länkar: | http://link.springer.com/article/10.1186/s12885-020-07155-y |